PHC Accelacare — Statesville, North Carolina

PHC Accelacare is a clinical research site located in Statesville, North Carolina, United States 28625.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PHC Accelacare has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Obesity, Heart Failure.

Sponsors: Novo Nordisk A/S.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Statesville

Browse all research sites in North Carolina · View every site in Statesville

• Cancer Center at Iredell Memorial Hospital
• Iredell Memorial Hospital
• Research Site
• Novant Health Cancer Institute - Statesville
• GSK Investigational Site
• Piedmont Healthcare/Research
• Piedmont Healthcare
• Wake Forest Baptist Health - Hematology Oncology - Statesville
• Carolinas Center for Liver Disease
• Novo Nordisk Investigational Site
• PMG Research of Piedmont Healthcare
• Novant Health Oncology Specialists-Statesville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PHC Accelacare?

PHC Accelacare has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PHC Accelacare conducted?

PHC Accelacare has 1 clinical trials on record, with 1 currently active. Their work covers Obesity, Heart Failure.

Is PHC Accelacare accredited by Crixeo Clinical Trials?

PHC Accelacare has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PHC Accelacare?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.